Nathalie Balla - Jun 5, 2023 Form 4 Insider Report for Criteo S.A. (CRTO)

Role
Director
Signature
/s/ Ryan Damon, as attorney-in-fact for Nathalie Balla
Stock symbol
CRTO
Transactions as of
Jun 5, 2023
Transactions value $
-$90,145
Form type
4
Date filed
6/7/2023, 04:08 PM
Previous filing
Mar 8, 2023
Next filing
Nov 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRTO Ordinary Shares Options Exercise $114K +6.1K +34.24% $18.71 23.9K Jun 5, 2023 Direct F1, F2, F3
transaction CRTO Ordinary Shares Sale -$204K -6.1K -25.51% $33.50 17.8K Jun 5, 2023 Direct F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRTO Non-employee Warrant (right to buy) Options Exercise $0 -6.1K -64.86% $0.00 3.3K Jun 5, 2023 Ordinary Shares 6.1K $18.71 Direct F1, F2, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.71 using the exchange rate as of June 5, 2023 (1.00 = $ 1.073).
F3 For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
F4 The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.44 to $33.685 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Warrant granted on October 24, 2019. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 24, 2029.